Given all the above data, we conclude that catalpol attenuates pulmonary fibrosis by inhibiting Ang II/AT1 and TGF-β/Smad-mediated epithelial mesenchymal transition (Figure 5). The gene discussed is TGFB1; the disease is pulmonary fibrosis.